ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
First Advantage Corporation

First Advantage Corporation (FA)

16.22
0.17
(1.06%)
Closed March 29 04:00PM
16.22
0.00
(0.00%)
After Hours: 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
16.22
Bid
16.04
Ask
23.40
Volume
600,407
16.07 Day's Range 16.32
12.10 52 Week Range 17.49
Market Cap
Previous Close
16.05
Open
16.09
Last Trade Time
Financial Volume
$ 9,727,160
VWAP
16.2009
Average Volume (3m)
463,720
Shares Outstanding
145,160,557
Dividend Yield
-
PE Ratio
63.14
Earnings Per Share (EPS)
0.26
Revenue
763.76M
Net Profit
37.29M

About First Advantage Corporation

First Advantage Corp is a risk mitigation and business solutions provider. It operates in six primary business segments: Lender Services, Data Services, Dealer Services, Employer Services, Multifamily Services and Investigative & Litigation Support Services. First Advantage Corp is a risk mitigation and business solutions provider. It operates in six primary business segments: Lender Services, Data Services, Dealer Services, Employer Services, Multifamily Services and Investigative & Litigation Support Services.

Sector
Business Services, Nec
Industry
Business Services, Nec
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
First Advantage Corporation is listed in the Business Services sector of the NASDAQ with ticker FA. The last closing price for First Advantage was $16.05. Over the last year, First Advantage shares have traded in a share price range of $ 12.10 to $ 17.49.

First Advantage currently has 145,160,557 shares outstanding. The market capitalization of First Advantage is $2.35 billion. First Advantage has a price to earnings ratio (PE ratio) of 63.14.

FA Latest News

First Advantage Introduces Next-Gen RightID™ to Detect Job Applicant Fraud in Pre-Hire Process

ATLANTA, March 11, 2024 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of employment background screening, identity, and verification solutions, today announced...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 425 - Prospectuses and communications, business combinations

  UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934...

Form 8-K - Current report

0001210677False00012106772024-02-282024-02-28  UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the...

Form 425 - Prospectuses and communications, business combinations

Filed by First Advantage Corporationpursuant to Rule 425 under the Securities Act of 1933 Subject Company: Sterling Check Corp.Commission File No.: 001-40829Date: February 29, 2024 [The...

Form 425 - Prospectuses and communications, business combinations

Filed by First Advantage Corporation pursuant to Rule 425 under the Securities Act of 1933 Subject Company: Sterling Check Corp. Commission File No.: 001-40829 Date: February 29, 2024...

Form 425 - Prospectuses and communications, business combinations

Filed by First Advantage Corporationpursuant to Rule 425 under the Securities Act of 1933 Subject Company: Sterling Check Corp.Commission File No.: 001-40829Date: February 29, 2024  TO:...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.221.3751616.3215.5189737815.96237536CS
41.5410.490463215314.6816.4114.010688165415.88255988CS
120.422.658227848115.817.4914.010646372016.10068088CS
262.3817.196531791913.8417.4912.4638727515.51354499CS
522.3416.858789625413.8817.4912.135275314.83210835CS
156-3.63-18.287153652419.8524.7310.0744625716.142251CS
260-3.63-18.287153652419.8524.7310.0744625716.142251CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

Discussion

View Full Feed
Bull_Dolphin Bull_Dolphin 2 minutes ago
Ahhh, that leisurely retirement in the fine city of Oakland:

https://www.breitbart.com/crime/2024/03/28/102-year-old-disabled-california-man-fined-thousands-graffiti-left-property/
MrPennyBags MrPennyBags 3 minutes ago
I say this is primed to move up soon. It's a perfect time to load and seems to be holding strong at these levels.
MOBILEUSD
sylvia07 sylvia07 6 minutes ago
This stock down now but will go back up, big investor, Rothschild, good for 120 million shares.
RNLX
Steady_T Steady_T 6 minutes ago
I agree with your post. I would suggest one small change. It is not that an NDA or MAA can be filed but rather that one is approved.
AVXL
Bull_Dolphin Bull_Dolphin 7 minutes ago
Why RFK would be unpopular on this board:

https://thefederalist.com/2024/03/28/rfk-jr-cant-keep-up-moderate-facade-while-celebrating-violent-radical-cesar-chavez/
FutureGNR FutureGNR 8 minutes ago
I guess no students of history here...

.
.
.
.
SEV
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 13 minutes ago
Where is the MAA? Where is the NDA?

Positive peer review means zilch even if it ever happens.

Only filings for Approval will get AVXL to stop spiralling round the toilet.

Get it done already, Dr. M.
AVXL
newmedman newmedman 13 minutes ago
https://twitter.com/traecrowder/status/1773442173125726248
PennMilitia PennMilitia 15 minutes ago
You can say that again

Give me a break with some of these people.
FNMA
Letterpenny Letterpenny 16 minutes ago
Thanks bud. I’m glad you know where you stand. Wink wink. lol. Yes bud. Being honest with oneself is a good thing. I tend to always need a good smack to wake me up. My stench is just as bad as everyone else’s stench. I try to always keep in mind my limits bud. Unfortunately I also believe that no
sylvia07 sylvia07 16 minutes ago
Declaes, I agree with you!
GRST
sylvia07 sylvia07 16 minutes ago
Declaes, I agree with you!
GRST
knrorrel knrorrel 18 minutes ago
thx yeeees 100 pro agreement $BDPT looks great now , .005 soon back or pennyland
imho

BDPT
boi568 boi568 19 minutes ago
The merits of the trial results aren't affected, of course, by a change to FDA guidance. But that won't matter if a change to the FDA guidance changes the criteria for approval in Anavex's favor. All this is obvious: If the weak spot in the 2b/3 is the ADL outcome and if now the FDA is abandoning th
AVXL
janice shell janice shell 19 minutes ago
A very educational video. I am astonished that they survived!
knrorrel knrorrel 20 minutes ago
thx $BDPT looks great now , .005 soon back or pennyland
imho

BDPT
kevin 3 kevin 3 20 minutes ago
IF YOU WOULD LIKE TO PUT A LITTLE " WAGER " ON IT I WILL HAVE HIM POST HIS
(( T.D. - CHARLES SCHWAB ACC. V.X.I.T. SELL HISTORY )). AND " JBB4321 AND HUSSLER NONE OF THEM HAVE SOLD SHARES .
VXIT
knrorrel knrorrel 21 minutes ago
$NWPN wow thx , should moving hard https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174139311
imho

NWPN
knrorrel knrorrel 23 minutes ago
$NWPN wow thx , should moving hard https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174139311
imho

NWPN
newmedman newmedman 23 minutes ago
pbs.twimg.com/media/GJxqQWlX0AAWx91?format=jpg&name=med
lakers17 lakers17 24 minutes ago
Not in the OTC overall this year in my opinion. There will be selective winners but nothing remotely like 2021 where everything went up in the OTC. In early 2021 there was not one reporting trip play left. All were .001 or above. We will never see an OTC market like that again. Towards the end u
NWPN
vdt vdt 24 minutes ago
Good news for MTNB
"We project that the market for MAT2203 in the treatment of invasive aspergillosis in patients with limited treatment options could reach peak sales in the U.S. alone of over $400 million annually..."
MTNB
Pharma Sleuth Pharma Sleuth 27 minutes ago
Haven't really read it at this hour but it seems one is to provide employees stock options. That's awesome. Good for them. They are the ones actually doing the work.

And the other is paying Nasrat his shares he already worked for in lieu of salary

Cleaning up the over
ELTP
knrorrel knrorrel 27 minutes ago
thx , that's annoying, but if we reach 0.007 or more, then you'll have your 10Bagger too... just wait a few weeks and see how everything develops
imo

TMSH

Your Recent History

Delayed Upgrade Clock